High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

OBJECTIVE: To evaluate the efficacy of rituximab (R) when added to high-dose methotrexate (HD-MTX) in patients with newly diagnosed immunocompetent primary CNS lymphomas (PCNSLs). METHODS: Immunocompetent adults with newly diagnosed PCNSL treated at The Johns Hopkins Hospital between 1995 and 2012 w...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Holdhoff, Matthias, Ambady, Prakash, Abdelaziz, Ahmed, Sarai, Guneet, Bonekamp, David, Blakeley, Jaishri, Grossman, Stuart A., Ye, Xiaobu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117362/
https://ncbi.nlm.nih.gov/pubmed/24928128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000593
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia